Reduced-Dose Imaging		Search  Back   Dose-Reduction Solution   Low Dose imaging protocols with no compromise in outcomes Dose Reduction at Multiple Sites, August 2011 UPPI Successfully Rolls Out UltraSPECT WBR Distribution Agreement Product launches FDA Cleared Xpress.PET SNM 2011 Press releases August 23, 2011 May 26, 2011 March 28, 2011 March 2, 2011 Product advertisements "Half the Dose. Twice the Speed.", JNC 2011 Scientific papers on WBR JNC 2011 JNC 2011
		UltraSPECT is a leading provider of reduced-dose image reconstruction products. Based on proprietary, innovative reconstruction algorithms technology, Wide-Beam Reconstruction (WBRTM), the Company's imaging solutions shorten acquisition times, enable reduced radiopharmaceutical dosage, and increase image resolution. UltraSPECT products include: Xpress.CardiacTM - can cut the radiopharmaceutical dose or shorten image acquisition times by 50% Xpress3.CardiacTM - can cut the radiopharmaceutical dose by 50% and shorten image acquisition times by up to 75%. Xpress/Xact.BoneTM - can either cut bone imaging acquisition times by 50%, or double the image resolution. None of these enhancements compromise image quality—in fact, image quality is improved in all applications. UltraSPECT is a leading provider of Nuclear Medicine